What's Happening?
VENN, a Korean beauty brand, has launched two new products, the Active Liquid Shot 0.1 and the Regenerative 10B-EXO EGF Ampoule, designed to achieve 'bloom skin,' a new term for the radiant effect previously known as 'glass skin.' The Active Liquid Shot 0.1 incorporates
spicules, microscopic needle-shaped structures from marine sponges, to create micro-channels in the skin, enhancing ingredient absorption. It also contains active ingredients like 4% niacinamide, 2% tranexamic acid, Centella exosome vesicles, and Compound K. The Regenerative 10B-EXO EGF Ampoule utilizes plant-derived exosomes from ginseng berry & root, Centella, Artemisia, and buckwheat, along with 10 ppm vegan EGF, to promote deep hydration, barrier repair, and firmer, more even-looking skin. These products are intended to be used together, with the Active Liquid Shot as a prep step followed by the ampoule, 1-3 times per week, alternated with retinoids or acids.
Why It's Important?
The introduction of VENN's new K-beauty duo, featuring spicules and exosomes, marks a significant development in the U.S. skincare market, particularly within the anti-aging and skin-refinement segments. This launch caters to a growing consumer demand for advanced, science-backed skincare solutions that promise visible results. The use of spicules, described as 'at-home liquid microneedling,' offers a less invasive alternative to professional treatments, making advanced skincare more accessible to a broader audience. Exosomes, as signaling packets that enhance skin's natural processes, represent a cutting-edge ingredient that could set new standards for efficacy in hydration, barrier repair, and anti-aging. For consumers, these products offer a sophisticated approach to achieving radiant skin, potentially reducing the need for multiple single-ingredient products. For the beauty industry, VENN's innovation highlights the continuous evolution of K-beauty trends and their influence on global product development, pushing competitors to explore similar advanced technologies and ingredients.
What's Next?
The market will closely observe the adoption and efficacy of VENN's new spicule and exosome products. If successful, these ingredients could become more prevalent in mainstream U.S. skincare, leading other brands to develop similar formulations. Consumers will likely share their experiences, influencing product reviews and sales. The brand's emphasis on 'bloom skin' as the new 'glass skin' may also shift beauty terminology and marketing focus within the industry. Further research and clinical studies on the long-term benefits and safety of spicules and plant-derived exosomes in skincare are anticipated. The regulatory landscape for such advanced ingredients may also evolve as their use becomes more widespread. VENN's success could solidify its position as a leader in innovative K-beauty, encouraging continued investment in research and development for novel skincare solutions.
Beyond the Headlines
The integration of spicules and exosomes into skincare products like VENN's new duo raises deeper questions about the future of cosmetic science and consumer expectations. Spicules, by creating micro-channels, blur the line between topical application and minimally invasive procedures, potentially democratizing access to treatments previously confined to clinics. Exosomes, as cell-signaling agents, represent a move towards bio-mimetic skincare, where products aim to communicate with and optimize the skin's natural functions. This trend reflects a broader societal interest in longevity and 'biohacking' for beauty. However, it also brings considerations regarding the sourcing and ethical implications of such ingredients, particularly as the distinction between plant-derived and human-derived exosomes is highlighted. The shift from 'glass skin' to 'bloom skin' also indicates the dynamic nature of beauty ideals, constantly evolving and driven by innovation and cultural influences, particularly from the vibrant K-beauty sector.













